Effect of once ‐weekly semaglutide on the counterregulatory response to hypoglycaemia in subjects with type 2 diabetes: a randomised, placebo‐controlled, double‐blind, crossover trial

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 12, 2018 Category: Endocrinology Authors: Stefan Korsatko , Lene Jensen , Martina Brunner , Stefanie Sach ‐Friedl , Maja D. Tarp , Anders G. Holst , Simon R. Heller , Thomas R. Pieber Source Type: research